newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common Stock

MALVERN, Pa., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for acute care settings, today announced that its Board of Directors declared a di